Colocalization of Estrogen Receptors with the Fluorescent Tamoxifen Derivative, FLTX1, Analyzed by Confocal Microscopy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4939-3127-9_13PMID 26585134
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Second malignancies after breast cancer: The impact of adjuvant therapy.

  2014cited by this paper
• High efficiency amplified spontaneous emission from a fluorescent anticancer drug-dye complex

  2013cited by this paper
• Unique SERM-like properties of the novel fluorescent tamoxifen derivative FLTX1.

  2013cited by this paper
• Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.

  2012cited by this paper
• Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen

  2004cited by this paper
• Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.

  2003cited by this paper
• Selective estrogen receptor modulators: structure, function, and clinical use.

  2000cited by this paper
• Basic guide to the mechanisms of antiestrogen action.

  1998cited by this paper

• Optical and random laser properties of the novel multifunctional endoxifen derivative (FLTX3) and its potential for the diagnosis of breast cancer resistance.

  2025cites this paper
• Fluorescent tamoxifen derivatives as biophotonic probes for the study of human breast cancer and estrogen-receptor directed photosensitizers

  2023cites this paper
• Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis

  2023cites this paper
• FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties

  2021cites this paper
• FRET mechanism between a fluorescent breast-cancer drug and photodynamic therapy sensitizers.

  2020cites this paper
• Opto-chemical and laser properties of FLTX1, a novel fluorescent tamoxifen derivative, and its potential applications in breast cancer photodynamic chemotherapy

  2018cites this paper